Skip to content

Dr. Thomas Verdonck

Active
Private limited companyfounded 20224 yrs activeTolstraat 64, 2000 Antwerpen, BelgiumKBO/BCE: BE 0780.711.923

Dr. Thomas Verdonck has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €155k and a net result of €51k. Equity is growing by ~47.5% per year across the filed fiscal years. Its solvency ranks better than 53% of 2152 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2024
94 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability96▼-4
Solvency92=
Growth52=
Track record94
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €14k at 30 days acceptable
Liquidity ample (current ratio 4.33 against 3.95 in 2023; short-term debt: 21.1% and cash: 88.3% of total assets), and 33.3% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Four signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 4 years 0 10 y
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 17-09-2025, 48 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 3 filings
Deviation from the deadline
2025
not confirmed
2024
48 d late
2023
57 d late
2022
32 d late
← before the deadline after the deadline →
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2024, abbreviated schema

Equity
€155k▲ 48.3%
2023 · €105k
2022: €56k 2023: €105k
2022 → 2024
Total assets
€233k▲ 49.1%
2023 · €156k
2022: €113k 2023: €156k
2022 → 2024
Net result
€51k▲ 3.5%
2023 · €49k
2022: €55k 2023: €49k
2022 → 2024
Working capital
€163k▲ 59.6%
2023 · €102k
2022: €51k 2023: €102k
2022 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line202220232024Trend
Equity€56k-€105k▲ 87.6%€155k▲ 48.3%
Operating result€77k-€70k▼ 8.9%€72k▲ 2.7%
Net result€55k-€49k▼ 10.8%€51k▲ 3.5%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€0€20k€40k€60k€80kOperating result 2022: €77k€77kNet result 2022: €55k€55kOperating result 2023: €70k€70kNet result 2023: €49k€49kOperating result 2024: €72k€72kNet result 2024: €51k€51k202220232024
The operating result recovers in 2024; 2024 is 3% above 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €233k
Fixed assets €20k▲ 6.7%
Current assets €212k▲ 55.0%
Equity and liabilities €233k
Equity €155k▲ 48.3%
Debt €77k▲ 50.7%
The debt ratio rises from 32.9% to 33.3%. Equity and debt are higher.
Key figures and ratios
2024 value · change against 2023
EBITDA
€79k
2023 · €76k
Cash flow
€58k
2023 · €55k
Solvency
66.7%
2023 · 67.1%
Current ratio
4.33
2023 · 3.95
Quick ratio
4.33
2023 · 3.95
Debt / equity
0.50
2023 · 0.49
ROE
32.6%
2023 · 46.7%
ROA
21.7%
2023 · 31.3%
Interest coverage
201.09
2023 · 135.37
Debt
€77k
2023 · €51k
Debt ≤ 1 year
€49k
2023 · €35k
Debt > 1 year
€6k
2023 · €13k
Income taxes
€21k
2023 · €20k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet Code20232024
Assets
Total assets20/58€156k€233k
Fixed assets21/28€19k€20k
Tangible fixed assets22/27€19k€20k
Plant, machinery and equipment23-€2k
Furniture and vehicles24€19k€19k
Current assets29/58€137k€212k
Amounts receivable within one year40/41€236€6k
Trade receivables40€236€0
Other amounts receivable41-€6k
Cash at bank and in hand54/58€136k€205k
Deferred charges and accrued income490/1€896€688
Equity and liabilities
Total equity and liabilities10/49€156k€233k
Equity10/15€105k€155k
Contributions10/11€1k€1k=
Reserves13€104k€154k
Distributable reserves133€104k€154k
Amounts payable17/49€51k€77k
Amounts payable after more than one year17€13k€6k
Financial debts170/4€13k€6k
Amounts payable within one year42/48€35k€49k
Current portion of amounts payable after more than one year42€7k€7k
Trade debts44€6k€7k
Suppliers440/4€6k€7k
Taxes, remuneration and social security45€14k€35k
Taxes450/3€14k€35k
Other amounts payable47/48€7k€0
Accrued charges and deferred income492/3€4k€23k
Income statement Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€6k€7k
Other operating charges640/8€712€563
Gross operating margin9900€76k€79k
Operating profit (loss)9901€70k€72k
Financial income75/76B€10€412
Recurring financial income75€10€412
Financial charges65/66B€559€391
Recurring financial charges65€559€391
Profit (loss) for the period before taxes9903€69k€72k
Income taxes67/77€20k€21k
Profit (loss) for the period9904€49k€51k
Profit (loss) for the period to be appropriated9905€49k€51k
Appropriation of the result
Profit (loss) to be appropriated9906€49k€51k
Transfer to equity691/2€49k€51k
To other reserves6921€49k€51k
Social balance
Average headcount (FTE)90870.00.0=

The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

2025
17-09
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema · 48 days late
2024
31-12
Financial Equity above €150kEq €155k ▲48.3%
3 profitable years in a row build equity to €155k.
26-09
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema · 57 days late
2023
31-12
Financial Weakest financial yearnet €49k ▼10.8%
Net result drops to €49k, the lowest in the series; recovery starts the following year.
31-12
Financial Equity above €100kEq €105k ▲87.6%
2 profitable years in a row build equity to €105k.
01-09
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema · 32 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Antwerpen · 1 establishment unit since 2022
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Tolstraat 642000 Antwerpen
Ground area
200 m²
Building footprint
149 m²
Volume, LiDAR
1,878 m³
Parcel 11811L3583/00P002, Flanders · tallest building 18.8 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
Dr. Thomas Verdonck
Tolstraat 64, 2000 AntwerpenSpecialist medical practice
since 20222.326.831.149
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
11811L3583/00P002 Flanders 200 m² 1 · 149 m² 18.8 m · 5 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 16,628 companies in sector 86220 we hold annual accounts for 7,973. 6,762 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded20-01-2022
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers

Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.

Contact details

2 entries
Enterprise
Phone:032374447
Enterprise